PLATELET AND LIPOPROTEIN FUNCTION IN AFRICAN-AMERICANS

非裔美国人的血小板和脂蛋白功能

基本信息

项目摘要

High blood pressure and vascular dysfunction strike African Americans with greater frequency and severity than the American population in general, and Caucasians in particular. Vascular disease, including hypertension accounts for a disproportionately elevated morbidity and mortality in this minority group. Why vascular disease is elevated in African Americans is not clear and constitutes a primary objective of this proposal. Insulin resistance (IR) has been identified as a factor cosegregating with hypertension in African Americans. A strong correlation of IR with borderline hypertension in African Americans has been documented, suggesting that it may be causally related to the development of hypertension in African Americans. There is evidence that IR contributes not only to the etiology of hypertension, but also to obesity, non-insulin dependent diabetes mellitus and atherogenic dyslipidemia. These four conditions constitute the cardinal risk factors for the development of atherosclerosis, the underlying disorder in myocardial infarction, stroke and claudication, all of which are elevated in African Americans. Little is known of the mechanistic basis by which IR contributes to hypertension or vascular dysfunction in general. This study will focus on two principle factors which are altered in IR and known to contribute to the overall well being of the vasculature, circulating platelets and serum lipoproteins. Preliminary data indicates that platelets from IR, hypertensive African Americans have augmented Ca++ uptake and elevated cytosolic Ca++ levels compared to control subjects. We also found elevated cholesterol content of the platelet membrane, implicating abnormalities in platelet membrane composition and structure with the altered Ca++ handling. The dyslipidemia of IR may mediate platelet and arterial smooth muscle cell (SMC) membrane abnormalities and thus, cell function abnormalities. We hypothesize that IR contributes to alterations in the biological properties of circulating platelets and/or lipoproteins and thereby contributes to the development of arterial disease, including hypertension in African Americans and explains their elevated cardiovascular risk. Accordingly, we will test: 1.) whether platelets from IR, hypertensive African Americans display altered calcium handling, membrane composition/structure and aggregatory activity; 2.), whether LDL from IR, hypertensive African Americans can induce alterations in platelet and human SMC function and/or alter Ca++ metabolism; and 3.) whether HDL from IR, hypertensive African Americans can reverse atherosclerosis- induced alterations in SMC function. This study will use freshly isolated platelets and lipoproteins to study their mutual interactions and their effects on human SMC cells in culture. Ca++ metabolism will be assessed using 45Ca++ and Fura-2 techniques, and membrane structural parameters assessed using x-ray diffraction techniques in an effort to shed light on the role of altered platelets and lipoproteins in IR and its relationship to cardiovascular risk in African Americans.
高血压和血管功能障碍是非洲裔美国人的常见疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas N. Tulenko其他文献

Human Adult Stem Cells Restore Endothelial Migratory Dysfunction in a Hypoxic Environment
  • DOI:
    10.1016/j.jvs.2010.06.065
  • 发表时间:
    2010-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sarah Fernandez;Rachel Song;Jason Comeau;Stephen McIlhenny;Hamid Abdollahi;Ping Zhang;Thomas N. Tulenko;Paul J. DiMuzio
  • 通讯作者:
    Paul J. DiMuzio

Thomas N. Tulenko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas N. Tulenko', 18)}}的其他基金

MEMBRANE DEFECT IN THE SLO SYNDROME
SLO 综合征中的膜缺陷
  • 批准号:
    6926154
  • 财政年份:
    2002
  • 资助金额:
    $ 19.93万
  • 项目类别:
MEMBRANE DEFECT IN THE SLO SYNDROME
SLO 综合征中的膜缺陷
  • 批准号:
    6659794
  • 财政年份:
    2002
  • 资助金额:
    $ 19.93万
  • 项目类别:
MEMBRANE DEFECT IN THE SLO SYNDROME
SLO 综合征中的膜缺陷
  • 批准号:
    6542916
  • 财政年份:
    2002
  • 资助金额:
    $ 19.93万
  • 项目类别:
MEMBRANE DEFECT IN THE SLO SYNDROME
SLO 综合征中的膜缺陷
  • 批准号:
    6781828
  • 财政年份:
    2002
  • 资助金额:
    $ 19.93万
  • 项目类别:
SMOOTH MUSCLE CELL MEMBRANE DURING ATHEROGENESIS
动脉粥样硬化过程中的平滑肌细胞膜
  • 批准号:
    6045027
  • 财政年份:
    2000
  • 资助金额:
    $ 19.93万
  • 项目类别:
SMOOTH MUSCLE CELL MEMBRANE DURING ATHEROGENESIS
动脉粥样硬化过程中的平滑肌细胞膜
  • 批准号:
    6537935
  • 财政年份:
    2000
  • 资助金额:
    $ 19.93万
  • 项目类别:
SMOOTH MUSCLE CELL MEMBRANE DURING ATHEROGENESIS
动脉粥样硬化过程中的平滑肌细胞膜
  • 批准号:
    6638725
  • 财政年份:
    2000
  • 资助金额:
    $ 19.93万
  • 项目类别:
SMOOTH MUSCLE CELL MEMBRANE DURING ATHEROGENESIS
动脉粥样硬化过程中的平滑肌细胞膜
  • 批准号:
    6390953
  • 财政年份:
    2000
  • 资助金额:
    $ 19.93万
  • 项目类别:
SMOOTH MUSCLE CELL MEMBRANE DURING ATHEROGENESIS
动脉粥样硬化过程中的平滑肌细胞膜
  • 批准号:
    6684097
  • 财政年份:
    2000
  • 资助金额:
    $ 19.93万
  • 项目类别:
PLATELET AND LIPOPROTEIN FUNCTION IN AFRICAN-AMERICANS
非裔美国人的血小板和脂蛋白功能
  • 批准号:
    6032130
  • 财政年份:
    1993
  • 资助金额:
    $ 19.93万
  • 项目类别:

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 19.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
  • 批准号:
    23K15842
  • 财政年份:
    2023
  • 资助金额:
    $ 19.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
  • 批准号:
    2880683
  • 财政年份:
    2023
  • 资助金额:
    $ 19.93万
  • 项目类别:
    Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 19.93万
  • 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 19.93万
  • 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
  • 批准号:
    10589484
  • 财政年份:
    2023
  • 资助金额:
    $ 19.93万
  • 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
  • 批准号:
    10585070
  • 财政年份:
    2023
  • 资助金额:
    $ 19.93万
  • 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
  • 批准号:
    10570469
  • 财政年份:
    2023
  • 资助金额:
    $ 19.93万
  • 项目类别:
2023 Atherosclerosis
2023 动脉粥样硬化
  • 批准号:
    10675221
  • 财政年份:
    2023
  • 资助金额:
    $ 19.93万
  • 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
  • 批准号:
    10619831
  • 财政年份:
    2023
  • 资助金额:
    $ 19.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了